A detailed history of Pacific Sage Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pacific Sage Partners, LLC holds 5,325 shares of AMGN stock, worth $1.71 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
5,325
Previous 5,483 2.88%
Holding current value
$1.71 Million
Previous $1.58 Billion 4.13%
% of portfolio
0.39%
Previous 0.43%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$268.87 - $324.56 $42,481 - $51,280
-158 Reduced 2.88%
5,325 $1.51 Billion
Q3 2023

Oct 30, 2023

SELL
$218.65 - $271.46 $65,376 - $81,166
-299 Reduced 5.17%
5,483 $1.47 Billion
Q2 2023

Jul 20, 2023

BUY
$214.27 - $253.37 $214 - $253
1 Added 0.02%
5,782 $1.28 Billion
Q1 2023

May 02, 2023

BUY
$225.79 - $275.2 $225 - $275
1 Added 0.02%
5,781 $1.4 Billion
Q4 2022

Jan 31, 2023

BUY
$229.03 - $291.01 $1.32 Million - $1.68 Million
5,780 New
5,780 $1.52 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pacific Sage Partners, LLC Portfolio

Follow Pacific Sage Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Sage Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Sage Partners, LLC with notifications on news.